ArticleBMC surgery2026
Analysis of risk factors for recurrence in septated chronic subdural hematoma.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSeptated chronic subdural hematoma (sCSDH), characterized by its multiseptated or multilayered appearance, poses unique therapeutic challenges due to its considerable recurrence rate. This study aimed to estimate the recurrence rate of sCSDH and identify independent risk factors associated with its recurrence.
methodsWe retrospectively analyzed clinical data from consecutive patients with sCSDH who underwent surgical therapy at our institution. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for sCSDH recurrence.
resultsA total of 137 patients with sCSDH underwent surgical treatment, of whom 32 (23.4%) experienced postoperative recurrence. Univariate analysis demonstrated significant associations between sCSDH recurrence and hematoma density (p < 0.001), separation types (p < 0.001), surgical technique (p = 0.002), and resilience of midline shift at the third postoperative day (p = 0.005). Multivariate logistic regression analysis revealed that hybrid hyper dense and isodense hematomas (p = 0.012, OR = 18.74), multiple septations (p = 0.035, OR = 5.93), and honeycomb septations (p = 0.014, OR = 6.45) were independent risk factors for sCSDH recurrence. Endoscopic-assisted surgery significantly reduced recurrence risk compared to single burr hole drainage (OR = 0.256, p = 0.021), indicating that single burr hole drainage serves as an independent risk factor for recurrence. Notably, endoscopic-assisted surgery demonstrated comparable efficacy to craniotomy. However, after adjusting for confounding factors, no significant correlation was observed between midline shift resilience and recurrence rates (OR = 0.958, p = 0.020).
conclusionHybrid hyper dense and isodense hematomas, honeycomb septations, and single burr hole drainage were identified as independent predictors for sCSDH recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.